Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.
Clicks: 46
ID: 283401
2025
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
6.9
/100
23 views
23 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
| Reference Key |
kahraman2025realworld
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | S. Kahraman; E. Erul; O. Gumusay; D.C. Guven; Sercan Aksoy; G. Basaran; M. Seyyar; E. Sahin; D. Çabuk; E. Bayram; S. Paydaş; B. Demirel; A. Yaren; B. Gulbagci; I. Hacibekiroglu; N. K. Baytemur; U. Demirci; S. E. Davarci; H. Demir; Eda Eylemer Mocan; Ozlem Dogan; E. Çılbır; Alper Yaşar; I. V. Bayoglu; M. Hızal; E. Kayıkçıoğlu; Bulent Cetin; O. Acar; A. Erdoğan; Merve Keskinkilic; T. Yavuzşen; O. Unal; F. Yılmaz; Mutlu Doğan; S. Orhan; E. Çubukçu; C. Erol; T. Şakalar; O. Dulgar; Yusuf Karakaş; Gulhan Ozkanli; B. Duman; D. Işık; Muge Karaoglanoglu; S. Okutur; N. Yıldırım; E. Aydin; B. Uluç; M. Keser; Burak Bilgin; Asude Aksoy; Onder Eren; N. O. Kalkan; M. Er; Hakan Yucel; V. Sunar; N. Paksoy; D. Aydın; N. Turhal; S. Menekşe; E. Kut; M. Aykan; Ozlem Ozdemir; M. Ozcelik; Y. Iriagac; F. Selçukbiricik; Ali Inal; Nuri Karadurmus; M. Akıncı; M. Şendur |
| Journal | clinical breast cancer |
| Year | 2025 |
| DOI |
10.1016/j.clbc.2025.03.003
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.